Papillorenal syndrome secondary prevention

Papillorenal syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Differentiating Papillorenal syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Papillorenal syndrome secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Papillorenal syndrome secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Papillorenal syndrome secondary prevention
CDC on Papillorenal syndrome secondary prevention
Papillorenal syndrome secondary prevention in the news
Blogs on Papillorenal syndrome secondary prevention
Directions to Hospitals Treating Papillorenal syndrome
Risk calculators and risk factors for Papillorenal syndrome secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Management of the disease should be focused on preventing end-stage renal disease (ESRD) and/or vision loss. The treatment of hypertension may also preserve renal function.

Secondary Prevention

Management of the disease should be focused on preventing end-stage renal disease (ESRD) and/or vision loss. The treatment of hypertension may also preserve renal function. Renal replacement therapy is recommended, and vision experts may provide assistance to adapt to continued vision loss.